Director/PDMR Shareholding

RNS Number : 0753F

GlaxoSmithKline PLC

05 January 2010

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

On 31 December 2009, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £13.25 per Ordinary share and $42.40 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2009 to 31 December 2009:

Non Executive Director	Ordinary Shares	American Depository Shares (ADSs)
Sir Christopher Gent	2,547.17
Prof. Sir Roy Anderson	636.79
Dr Stephanie Burns		181.25
Mr Lawrence Culp		181.25
Sir Crispin Davis	2,358.49
Sir Deryck Maughan		181.25
Mr James Murdoch	495.28
Dr Daniel Podolsky		253.76
Mr Tom de Swaan	872.64
Sir Robert Wilson	636.79

The Company and the Non-Executive Directors were informed of these allocations on 4 January 2010.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

S M Bicknell

Company Secretary

5 January 2010

---

 

END

 

 

RDSQELFBBFFXBBB